ElucidVivo A.3 vs OMRON VitalSight

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

ElucidVivo A.3

by Elucid

OMRON VitalSight

by OMRON Healthcare

AI Verdict

Tool A, ElucidVivo A.3, is an AI-powered medical image analysis system focused on quantitative assessment of arterial plaque from CT angiography to aid in atherosclerosis patient stratification. Conversely, Tool B, OMRON VitalSight, is a remote patient monitoring service designed for hypertension management through connected blood pressure devices and EHR integration. While both operate within cardiology, their core functionalities diverge significantly, with one being a diagnostic imaging analysis tool and the other a chronic condition management platform.

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your primary need is advanced, AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography. This tool is ideal for cardiologists and vascular surgeons seeking to stratify atherosclerosis patients and optimize treatment decisions based on detailed visualization and measurement of plaque characteristics, including Lipid-Rich Necrotic Core (LRNC) and calcifications.

View ElucidVivo A.3 →

Choose OMRON VitalSight if…

Choose OMRON VitalSight if you require a comprehensive remote patient monitoring solution specifically for managing hypertension. This service is best suited for physicians looking to continuously track patient blood pressure readings, receive automatic notifications for out-of-range results, and seamlessly integrate data into their EHR/EMR to improve long-term patient outcomes.

View OMRON VitalSight →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	ElucidVivo A.3	OMRON VitalSight
Pricing	Unknown	Reimbursement-based
Deployment	Cloud and on-premise secure deployment.	Cloud-based (physician dashboard) with at-home patient devices.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

OMRON VitalSight

OMRON VitalSight (Tool B) prioritizes ease of use for both patients and physicians. Patients receive a pre-set kit delivered to their home, and the data hub operates without Wi-Fi or cellular connection, simplifying patient engagement. Physicians access data via a cloud-based dashboard or EHR integration, streamlining workflow. ElucidVivo A.3 (Tool A), while powerful, is a specialized medical imaging analysis system requiring professional operation, implying a steeper learning curve for its advanced visualization and quantitative analysis features.

Clinical Value

ElucidVivo A.3

ElucidVivo A.3 (Tool A) offers deep, quantitative diagnostic insights into arterial plaque composition and stability from CT angiography, validated against histology, and can derive fractional flow reserve (FFRct). This directly aids in precise atherosclerosis patient stratification and optimizes complex treatment decisions. OMRON VitalSight (Tool B) provides valuable remote monitoring for hypertension, improving long-term management and patient outcomes, but Tool A's detailed diagnostic capabilities for a high-risk condition represent a higher level of clinical insight and impact on critical interventions.

Pricing & Value

OMRON VitalSight

OMRON VitalSight (Tool B) offers a transparent, reimbursement-based pricing model, with no setup or device costs for physicians and generally little to no cost for patients depending on coverage, making it highly accessible and financially predictable. ElucidVivo A.3 (Tool A) requires contacting for pricing, which lacks transparency and makes it difficult to assess its value proposition without further inquiry.

Enterprise Readiness

OMRON VitalSight

Both tools are FDA-cleared and integrate with EHR/EMR systems. However, OMRON VitalSight (Tool B) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are critical assurances for enterprise adoption and data security. While ElucidVivo A.3 (Tool A) implies HIPAA compliance due to its FDA clearance and use in healthcare, the explicit confirmation from Tool B provides a stronger foundation for enterprise readiness.

Innovation

ElucidVivo A.3

ElucidVivo A.3 (Tool A) demonstrates higher innovation by applying advanced AI to perform quantitative analysis of arterial plaque composition and stability, including the objective quantification of Lipid-Rich Necrotic Core (LRNC) and derivation of FFRct, validated against ground-truth histology. This pushes the boundaries of non-invasive diagnostic capabilities in cardiovascular imaging. OMRON VitalSight (Tool B) offers innovation in service delivery and accessibility of remote patient monitoring, but its core technology is more established.

Support & Docs

Tie

The provided structured facts do not contain specific details regarding the support and documentation offerings for either ElucidVivo A.3 (Tool A) or OMRON VitalSight (Tool B). While OMRON Healthcare, as a larger entity, provides general product manuals and customer service for its various devices, specific comparative information on the quality, breadth, or accessibility of support and documentation for these particular healthcare-AI tools is not readily available through general web searches. Therefore, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	ElucidVivo A.3	OMRON VitalSight
Name	ElucidVivo A.3	OMRON VitalSight
Company	Elucid Bioimaging	OMRON Healthcare
Primary Purpose	AI-powered medical image analysis for quantitative analysis of arterial plaque composition and stability from CT angiography.	Remote patient monitoring service for US physicians, offering connected blood pressure monitors and data hubs to manage hypertension.
Primary Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Target Specialties	Cardiology, Radiology, Vascular Surgery	Cardiology, Internal Medicine, Nephrology

Videos

Demos, reviews, and walkthroughs featuring ElucidVivo A.3 and OMRON VitalSight.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does ElucidVivo A.3 integrate into the diagnostic workflow for atherosclerosis, and how does OMRON VitalSight fit into the ongoing management of hypertension patients?

ElucidVivo A.3 is designed to integrate into typical clinical workflow patterns for processing, reviewing, and analyzing digital images from CT angiography, assisting physicians in stratifying atherosclerosis patients and optimizing treatment decisions. OMRON VitalSight integrates into hypertension management by providing a remote patient monitoring service where connected blood pressure monitors securely share data with EHRs, enabling ongoing patient care and automatic notifications for out-of-range readings.

What are the specific capabilities of the EHR integration for each tool, particularly regarding data flow and physician interaction within the EHR?

OMRON VitalSight offers secure integration with a physician's EMR system or through its dashboard for easy data analysis, providing automatic notifications when patient readings require action. ElucidVivo A.3 supports DICOM integration and PACS/EMR interoperability, allowing its quantitative image analysis results and 3D visualizations of plaque characteristics to be incorporated into patient records.

For ElucidVivo A.3, what is the basis for its quantitative analysis accuracy, and for OMRON VitalSight, how does it ensure the reliability of remotely collected blood pressure data?

ElucidVivo A.3's quantitative analysis of arterial plaque composition, including Lipid-Rich Necrotic Core, matrix, and calcifications, is validated against ground-truth histology. OMRON VitalSight ensures data reliability through pre-set, connected blood pressure monitors and data hubs that securely share digital data, with the data hub operating without requiring Wi-Fi or cellular connections at the patient's home.

What is the expected learning curve for physicians and their clinical staff to effectively utilize ElucidVivo A.3's image analysis features and OMRON VitalSight's remote monitoring platform?

ElucidVivo A.3, as an AI-powered image analysis system providing detailed visualizations and quantitative metrics, would involve a learning curve for physicians to interpret and integrate these advanced insights into their diagnostic and treatment planning. OMRON VitalSight is designed for minimal training, with an EMR integration process that takes weeks rather than months, and pre-set patient devices, suggesting a lower learning curve for clinical staff.

Beyond standard compliance, what specific measures do ElucidVivo A.3 and OMRON VitalSight employ to ensure the security and integrity of sensitive patient data during analysis and transmission?

OMRON VitalSight utilizes pre-set devices and a data hub for secure, digital data sharing, with securely encrypted data automatically sent to the doctor's EMR in real time. ElucidVivo A.3, as an FDA-cleared medical image analysis system, adheres to SOC 2 and HIPAA-aligned data protection, with a focus on building secure systems from the ground up and employing monitoring and auditing controls for sensitive data.

What considerations should a multi-site practice or health system keep in mind when planning to implement either ElucidVivo A.3 or OMRON VitalSight across multiple locations?

For OMRON VitalSight, its cloud-based physician dashboard and direct-to-patient device delivery model, along with minimal setup and no device costs for physicians, suggest a scalable solution for multi-site rollouts. ElucidVivo A.3, as a software application with DICOM integration and PACS/EMR interoperability, would require careful planning for consistent deployment and integration across various imaging departments and IT infrastructures in a multi-site health system.